Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Pharmalot
Biotech
Health
The Readout

Pondering an Obamacareless future & using amyloids for good

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan Nov. 11, 2016

Reprints
The READOUT
Alex Hogan/STAT

The Readout for November 11, 2016

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Researching collagen to help his achy knees, a statistician…
Researching collagen to help his achy knees, a statistician explores the painfully weak evidence
What an 1890s opioid epidemic can teach us about…
What an 1890s opioid epidemic can teach us about ending addiction today
He Jiankui, embryo editing, CCR5, the London patient, and…
He Jiankui, embryo editing, CCR5, the London patient, and jumping to conclusions
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories